Trazodone for Anxiety: Does it Work and What Should You Know?
Author:
Blossom Editorial
Feb 25, 2026
Trazodone is best known as an antidepressant and sleep aid (off-label), but it is also used off-label for anxiety — sometimes as an alternative to commonly prescribed options like SSRIs or benzodiazepines. If your doctor has suggested trazodone for anxiety, or if you are curious whether it might be appropriate for your situation, understanding what the evidence says can help you have a more informed conversation with your provider.
Key Takeaways
Although trazodone is not FDA-approved for anxiety, it is sometimes used off-label for anxiety disorders. Some older clinical trials suggest it may reduce symptoms of generalized anxiety disorder (GAD), with trazodone achieving comparable efficacy to diazepam (Valium). However, the evidence base is limited compared to first-line treatments such as SSRIs and SNRIs.
Unlike benzodiazepines such as diazepam, trazodone is not habit-forming and does not carry the same risk of physical dependence. However, like many antidepressants, it should be tapered gradually under medical supervision to reduce the risk of discontinuation symptoms. Trazodone could be a useful alternative for people who need longer-term anxiety treatment.
Trazodone's dual effect on anxiety and sleep can be a significant advantage for people whose anxiety is closely tied to sleep difficulties, a very common combination.
What is Trazodone?
Trazodone (Raldesy) is a serotonin antagonist and reuptake inhibitor (SARI). It works by blocking serotonin receptors (particularly 5-HT2A and 5-HT2C) and inhibiting serotonin reuptake, which increases serotonin availability in the brain. It also blocks histamine H1 and alpha-1 adrenergic receptors, which contribute to its calming and sedating effects.
According to NCBI, trazodone is used off-label for anxiety, Alzheimer's disease, substance misuse, bulimia, fibromyalgia, and PTSD-related sleep disturbance, in addition to its approved use for major depressive disorder. The strength of evidence varies depending on the condition.
Does Trazodone Help with Anxiety? What the Research Shows
The use of trazodone for anxiety has been studied since the 1980s, and several trials have produced encouraging results for certain anxiety conditions.
Generalized Anxiety Disorder (GAD)
Positive evidence for trazodone in anxiety comes from a randomized, double-blind, placebo-controlled trial published in JAMA Psychiatry in 1993. The study enrolled 230 patients with GAD (excluding those with depression or panic disorder) and compared trazodone and imipramine — both antidepressants — with diazepam (a conventional anti-anxiety medication), and placebo over eight weeks.
The results: trazodone achieved comparable anxiolytic efficacy to diazepam from weeks three through eight. Moreover, psychic anxiety symptoms, including tension, apprehension, and worry, responded better to trazodone compared to diazepam. Among those who completed the trial, 69% of trazodone-treated patients reported moderate to marked improvement, compared to 66% in the diazepam group and 47% in the placebo group.
However, this evidence is older and has not been followed by large modern trials.
Panic Disorder
A smaller 1987 study examined trazodone in 11 patients with panic disorder or agoraphobia with panic attacks. Participants received 300 mg/day for eight weeks and showed significant improvement across all symptom dimensions, including generalized and panic anxiety, phobias, depression, and behavioral avoidance. The researchers concluded that trazodone may have specific anti-panic and anti-phobic actions.
That said, the study lacked a control group and was too small to draw firm conclusions.
PTSD-Related Sleep and Anxiety
A 2001 study found that trazodone may help with insomnia and nightmares associated with PTSD — two symptoms that often overlap with anxiety. According to a review published in CNS Drugs, trazodone can be used as an adjunct medicationin PTSD when first-line treatments such as SSRIs are ineffective or intolerable.
However, evidence primarily supports its role in improving sleep rather than treating core PTSD symptoms.
Limitations
While these findings are promising, it is important to note that the evidence base for trazodone in anxiety is smaller and somewhat older than the evidence for first-line treatments like SSRIs or SNRIs. Most anxiety guidelines recommend SSRIs or SNRIs as the first-line pharmacological treatment for anxiety disorders, with trazodone typically considered when those options have not worked or caused intolerable side effects.
How Trazodone Compares to Other Anxiety Medications
Understanding where trazodone fits can help clarify when it might be the right choice.
Trazodone vs. SSRIs
SSRIs — like sertraline, escitalopram, and fluoxetine — are the most commonly prescribed first-line medications for anxiety. Compared to SSRIs, trazodone offers some distinct advantages and trade-offs:
Sleep: SSRIs can worsen insomnia when first started, particularly during the initial weeks. Trazodone commonly improves sleep because of its sedating properties.
Sexual side effects: SSRIs are associated with high rates of sexual dysfunction. Trazodone is associated with a lower risk of sexual dysfunction compared to SSRIs, and in some cases has been used to address SSRI-related sexual side effects when used in combination.
Onset: Some patients experience increased jitteriness or anxiety when starting SSRIs. Although trazodone’s sedating effects may be noticeable after the first dose, its full anxiolytic benefits typically take several weeks.
Evidence: SSRIs have a much stronger and broader evidence base for anxiety disorders. Trazodone's evidence is limited to specific conditions and older studies.
Trazodone vs. Benzodiazepines
Benzodiazepines (like alprazolam/Xanax, diazepam/Valium, and lorazepam/Ativan) work quickly and are effective for acute anxiety. However, they carry significant risks of physical dependence, tolerance, and withdrawal. Because trazodone is generally not associated with benzodiazepine-related dependence or misuse risk, it may be considered in patients where long-term benzodiazepine use is not appropriate.
However, abruptly stopping trazodone can cause discontinuation symptoms. It is important to gradually taper trazodone under medical supervision.
Who Might Benefit from Trazodone for Anxiety?
Trazodone may be particularly appropriate for anxiety when:
You also struggle with insomnia; treating both with one medication can be efficient
You have not responded well to or cannot tolerate SSRIs or SNRIs
You have co-occurring depression alongside anxiety
You need to avoid habit-forming medications
You are looking for an alternative to benzodiazepines for longer-term management
You have experienced sexual side effects with other antidepressants
What to Expect if You Take Trazodone for Anxiety
Unlike benzodiazepines, which can reduce anxiety within hours, trazodone's anxiolytic effects build over time. Although its sedative effects become apparent within 1-2 hours of taking a dose, it typically takes two weeks or longer before you can feel trazodone’s effects on depression and anxiety. It may be four to six weeks before you get the full therapeutic benefits of trazodone. This is similar to the timeline for SSRIs and SNRIs.
The sedating effects of trazodone can be helpful if nighttime anxiety is a significant problem, but may be disruptive during the daytime if dosing is not managed carefully.
Common dosing for anxiety: When used for anxiety, trazodone dosing often mirrors antidepressant dosing, typically starting at lower doses (e.g., 50–100 mg daily) and titrating upward, with total daily doses commonly ranging from 150–400 mg (maximum dosage) depending on tolerability and response..
Side Effects to Know About
Trazodone's side effect profile is generally considered favorable, particularly compared to older antidepressants. However, some effects are worth knowing about:
Sedation: The most common effect — helpful at night, potentially problematic during the day
Dizziness or low blood pressure: Particularly when standing up quickly
Dry mouth and nausea: Usually mild and temporary
Priapism: A rare but serious side effect in males — prolonged, painful erection requiring emergency treatment
Cardiac effects: Trazodone has been associated with QT interval prolongation and arrhythmias in rare cases, and should be used cautiously in patients with cardiac disease or those taking other QT-prolonging medications.
Trazodone is not associated with sexual dysfunction or significant weight gain — two advantages over SSRIs and some other antidepressants.
When to Seek Professional Help for Anxiety
Anxiety disorders are among the most common mental health conditions in the United States, affecting approximately 19% adults annually, according to the National Institute of Mental Health (NIMH). Yet many people go untreated, either because they do not recognize their symptoms as anxiety or because they are unsure where to start.
Signs that your anxiety may benefit from professional evaluation include: persistent worry that is difficult to control, physical symptoms like racing heart or muscle tension, avoidance of situations that trigger anxiety, or sleep difficulties linked to anxious thoughts.
A psychiatrist can evaluate your symptoms, identify the type of anxiety disorder you may have, and recommend the most evidence-based treatment — whether that includes trazodone, another medication, therapy, or a combination.
At Blossom Health, licensed psychiatric providers offer virtual, in-network appointments to help you find the right approach for your anxiety — without the wait or the commute.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or qualified healthcare provider with questions about your medication. If you are experiencing a mental health crisis, call or text 988.
Sources
Brogden, R. N., Heel, R. C., Speight, T. M., & Avery, G. S. (1981). Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs, 21(6), 401–429. https://pubmed.ncbi.nlm.nih.gov/7018873/
Rickels, K., Downing, R., Schweizer, E., & Hassman, H. (1993). Antidepressants for the treatment of generalized anxiety disorder: A placebo-controlled comparison of imipramine, trazodone, and diazepam. Archives of General Psychiatry, 50(11), 884–895. https://jamanetwork.com/journals/jamapsychiatry/article-abstract/496392
Validus Pharmaceuticals LLC. (2025). Raldesy (trazodone hydrochloride) oral solution [Package insert]. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218637Orig1s002lbl.pdf
Fagiolini, A., Comandini, A., Catena Dell'Osso, M., & Kasper, S. (2012). Rediscovering trazodone for the treatment of major depressive disorder. CNS drugs, 26(12), 1033–1049. https://pmc.ncbi.nlm.nih.gov/articles/PMC3693429
Shin JJ, Saadabadi A. Trazodone. [Updated 2024 Feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470560/
Mavissakalian, M., Perel, J., Bowler, K., & Dealy, R. (1987). Trazodone in the treatment of panic disorder and agoraphobia with panic attacks. American Journal of Psychiatry, 144(6), 785–787. https://doi.org/10.1176/ajp.144.6.785
Warner, M. D., Dorn, M. R., & Peabody, C. A. (2001). Survey on the usefulness of trazodone in patients with PTSD with insomnia or nightmares. Pharmacopsychiatry, 34(4), 128–131. https://doi.org/10.1055/s-2001-15871
Bossini, L., Casolaro, I., Koukouna, D., Cecchini, F., & Fagiolini, A. (2012). Off-label uses of trazodone: A review. Expert Opinion on Pharmacotherapy, 13(12), 1707–1717. https://doi.org/10.1517/14656566.2012.699523
Fagiolini, A., Grošelj, L. D., Šagud, M., Silić, A., et al. (2025). Targeting heterogeneous depression with trazodone prolonged release: from neuropharmacology to clinical application. Annals of general psychiatry, 24(1), 31. https://pmc.ncbi.nlm.nih.gov/articles/PMC12096638/
. National Institute of Mental Health. (2024, December). Anxiety disorders. U.S. Department of Health and Human Services, National Institutes of Health. https://www.nimh.nih.gov/health/topics/anxiety-disorders
U.S. National Library of Medicine. (2025, October 15). Trazodone: MedlinePlus drug information. MedlinePlus. https://medlineplus.gov/druginfo/meds/a681038.html
Jaffer, K. Y., Chang, T., Vanle, B., Dang, J., Steiner, A. J., Loera, N., Abdelmesseh, M., Danovitch, I., & Ishak, W. W. (2017). Trazodone for Insomnia: A Systematic Review. Innovations in clinical neuroscience, 14(7-8), 24–34. https://pmc.ncbi.nlm.nih.gov/articles/PMC5842888/
